Vergesene Bio-Perle - 500 Beiträge pro Seite

[Zlotymannnn]

Ich möchte euch nur auf Curis 940909 aufmerksammachen.
Der Chart sieht sehr Gut aus und die producktpalette ist auch gut gefüllt.
Mein KZ 5$ in den nächsten Wochen.


Product Development Programs


Curis is developing product candidates in several important medical fields where there is substantial unmet therapeutic need. These product development initiatives (see chart below) either utilize internal Curis resources or have been partnered with pharmaceutical firms that bring additional resources and expertise to those programs. These product development programs derive primarily from Curis` substantial intellectual property in developmental biology signaling pathways.

Technology
Primary Indication
Partner
Status

BMP protein
Kidney Disease
Ortho Biotech (J&J)
late preclinical

Curis Licenses Bone Morphogenic Protein Technology to Ortho Biotech Products, L.P. (a member of the Johnson & Johnson family of companies)
Curis Compound, BMP-7, May Prevent Bone and Vascular Complications Associated with Chronic Kidney Disease
BMP-7 Found to Prevent Bone Disease in a Model of Chronic Kidney Failure
BMP-7 Reduces Inflammation and Improves Blood Flow In Models of Kidney Disease Indicating Novel Mechanism For Treatment
CURIS` BMP-7 Protein Drug Candidate Reported in American Heart Association publication to Enhance Stroke Recovery


Hh agonist
Neurological Disorders
seeking partner
mid preclinical

Curis Reports Pre-Clinical Study of its Hedgehog Signaling Pathway
Sonic Hedgehog Reduces Behavioral Impairment in a Primate Model of Parkinson`s Disease
Curis Proprietary Product, Hedgehog, Demonstrated to be a Key Factor in Formation of Nerve Cells
Hedgehog proteins reduce behavioral impairment in pre-clinical models of Parkinson`s disease


Hh antibody
Cancer
seeking partner
mid preclinical

CURIS Issued U.S. Patent Covering Cancer Drug Candidates

Dow Jones Business News: Curis Issued Patent Covering Cancer Drugs


Hh antagonist
BCC (Skin Cancer)
seeking partner
late preclinical

CURIS Issued U.S. Patent on Small Molecule Inhibitors of Hedgehog Pathway

CURIS Issued U.S. Patent Covering Cancer Drug Candidates

Dow Jones Business News: Curis Issued Patent Covering Cancer Drugs
Novel Drug Candidate Identified as Treatment for BCC

Curis Proprietary Product Cyclopamine Inhibits Medulloblastoma Growth (the most common malignant brain tumor in children)


PYY peptide
Obesity
Amylin
late preclinical

Curis Licenses PYY Patents to Amylin Pharmaceuticals for the Treatment of Metabolic Diseases including Obesity and Diabetes
An IND on PYY for an obesity indication is targeted to be filed in 2003


Stem cells
Diabetes
ES Cell
early preclinical

Curis Partners its Diabetes Program with ES Cell International


Hh agonist
Alopecia (Hair Loss)
proprietary
mid preclinical

Scientists at Curis have recently demonstrated that the Company`s small molecule Hh agonists can induce hair regrowth in an animal model







[ web master ] Copyright Curis Inc. 2003 - All rights Reserved

[gurkone]

so gut sieht der chart aber meiner Meinung nicht aus. Das Hoch vom Mai liegt unter dem vom April. Sicherlich ist der Aufwärtstrend noch intakt, aber es geht doch eher Richtung Dreiecksformation und deren Ausgang ist in den meisten Fällen ungewiss.
...aber interessanter Wert!!!
so long